Additional file 7: of Effects of novel HDAC inhibitors on urothelial carcinoma cells
- Aline Kaletsch (5576153)
- Maria Pinkerneil (3613667)
- Michèle Hoffmann (3449339)
- Ananda Jaguva Vasudevan (3422579)
- Chenyin Wang (5576156)
- Finn Hansen (5576159)
- Constanze Wiek (140463)
- Helmut Hanenberg (140467)
- Christoph Gertzen (5576162)
- Holger Gohlke (525601)
- Matthias Kassack (2160217)
- Thomas Kurz (1648405)
- Wolfgang Schulz (3449312)
- Günter Niegisch (3449342)
Publication date
July 2018
DOIAbstract
Figure S5. Expression of HDAC1, HDAC2 and HDAC6 mRNA following treatment of UCCs with 19i or SAHA. Effects of 24 and 48 h treatment with 19i (2 μM), SAHA (2.5 μM) or DMSO as solvent control on mRNA expression of HDAC1, HDAC2 and HDAC6 in VM-CUB1, UM-UC-3 and 639-V cells. All values indicate relative expression compared to a standard for each gene, adjusted to TBP as a reference gene and set as 1 for the solvent control. Significance levels likewise refer to the solvent control (* = p < 0.05). Data shown are mean from n = 3. (PDF 105 kb
Add to ORKG